Literature DB >> 22850989

Antibody levels to hantavirus in inhabitants of western Santa Catarina State, Brazil.

William Marciel de Souza1, Alex Martins Machado, Geonildo Rodrigo Disner, Everton Boff, Aline Rafaela da Silva Rodrigues Machado, Michelly de Padua, Luiz Tadeu Moraes Figueiredo, Gustavo Borba de Miranda.   

Abstract

Hantavirus cardiopulmonary syndrome (HCPS) is an infectious disease caused by hantaviruses of the family Bunyaviridae, and is transmitted by aerosols of excreta of infected rodents. The aim of the present study was to determine antibody levels to hantavirus in the population that lives at frontier of Brazil and Argentina. Participated of the study 405 individuals living in the municipalities of Bandeirante, Santa Helena, Princesa and Tunapolis, state of Santa Catarina, Brazil. IgG antibodies to hantavirus were analyzed in sera by an ELISA that uses a recombinant N protein of Araraquara hantavirus as antigen. The results were also confirmed by immunofluorescent test. Eight individuals showed antibodies to hantavirus (1.97% positivity), with serum titers ranging from 100 to 800. Six seropositives were males, older than 30 years and farmers. Our results reinforce previous data on hantavirus circulation and human infections in the southern border of Brazil with Argentina.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850989     DOI: 10.1590/s0036-46652012000400002

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  2 in total

1.  Development of a novel plaque reduction neutralisation test for hantavirus infection.

Authors:  Michelly de Pádua; William Marciel de Souza; Flávio Lauretti; Luiz Tadeu Moraes Figueiredo
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-30       Impact factor: 2.743

2.  Serologic survey on hantavirus in blood donors from the state of Santa Catarina, Brazil.

Authors:  Caio Maurício Mendes de Cordova; Luiz Tadeu Moraes Figueiredo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.